Document is current
Any future updates will be listed below
-
Authors
Leung, Ying Ying https://orcid.org/0000-0001-8492-6342
Eder, Lihi https://orcid.org/0000-0002-1473-1715
Orbai, Ana-Maria https://orcid.org/0000-0001-8644-8567
Coates, Laura C https://orcid.org/0000-0002-4756-663X
de Wit, Maarten https://orcid.org/0000-0002-8428-6354
Smolen, Josef S
Kiltz, Uta https://orcid.org/0000-0001-5668-4497
Palominos, Penélope https://orcid.org/0000-0003-0132-4325
Canete, Juan D https://orcid.org/0000-0003-2606-0573
Scrivo, Rossana
Balanescu, Andra
Dernis, Emanuelle
Meisalu, Sandra
Soubrier, Martin https://orcid.org/0000-0001-9349-0720
Kalyoncu, Umut
Gossec, Laure https://orcid.org/0000-0002-4528-310X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03119805 at ClinicalTrials.govnct03119805 at ClinicalTrials.govDocuments that mention this clinical trial
FRI0437 PATIENT-DEFINED FLARES IN IN PSORIATIC ARTHRITIS: WHAT DO THEY MEAN? AN ANALYSIS OF CHANGE BETWEEN 2 VISITS IN 222 PATIENTS
https://doi.org/10.1136/annrheumdis-2019-eular.2161
SAT0378 DRIVERS OF DISCORDANCE IN PSORIATIC ARTHRITIS WHEN ANALYZING THE LINK BETWEEN PATIENT-PERCEIVED GOOD STATUS AND THE DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (DAPSA) COMPOSITE SCORE: AN ANALYSIS OF 436 PATIENTS FROM THE INTERNATIONAL REFLAP OBSERVATIONAL STUDY
https://doi.org/10.1136/annrheumdis-2019-eular.1207
Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study
https://doi.org/10.1136/rmdopen-2023-003157
SAT0635 PATIENT-PERCEIVED RESIDUAL BURDEN OF PSORIATIC ARTHRITIS IN PATIENTS IN REMISSION/LOW DISEASE: AN ANALYSIS OF 444 PATIENTS
https://doi.org/10.1136/annrheumdis-2019-eular.1206
POS1076 OBESITY IS ASSOCIATED WITH LESS LIKELIHOOD OF REMISSION/ LOW DISEASE IN PSORIATIC ARTHRITIS, A CROSS-SECTIONAL STUDY OF 414 PATIENTS
https://doi.org/10.1136/annrheumdis-2022-eular.2099
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries
https://doi.org/10.1136/rmdopen-2021-002031
POS0004 WHAT DOES WORSENING IN DAPSA DISEASE ACTIVITY CATEGORIES MEAN FOR PATIENTS WITH PSORIATIC ARTHRITIS? AN ANALYSIS OF 222 PATIENTS
https://doi.org/10.1136/annrheumdis-2022-eular.1493
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries
https://doi.org/10.1136/annrheumdis-2018-214140
SAT0318 Do patients in remission in psoriatic arthritis, have less fatigue? and does this depend on the definition of remission? an analysis of 304 patients
https://doi.org/10.1136/annrheumdis-2018-eular.3106
SAT0664 RESPONSIVENESS OF PATIENT-REPORTED PHYSICAL FUNCTION OUTCOME MEASURES IN A REAL LIFE INTERNATIONAL COHORT OF 405 PATIENTS WITH PSORIATIC ARTHRITIS
https://doi.org/10.1136/annrheumdis-2019-eular.6761
OP0298 ARE PATIENTS WITH PSORIATIC ARTHRITIS BEING TREATED OPTIMALLY ACROSS THE WORLD? DISPARITIES IN HEALTH CARE FOR PATIENTS WITH PSORIATIC ARTHRITIS ACROSS COUNTRIES WITH DIFFERENT GDP'S, AN ANALYSIS OF 429 PATIENTS FROM 13 COUNTRIES
https://doi.org/10.1136/annrheumdis-2021-eular.1120
Documents that mention this clinical trial
FRI0437 PATIENT-DEFINED FLARES IN IN PSORIATIC ARTHRITIS: WHAT DO THEY MEAN? AN ANALYSIS OF CHANGE BETWEEN 2 VISITS IN 222 PATIENTS
https://doi.org/10.1136/annrheumdis-2019-eular.2161
SAT0378 DRIVERS OF DISCORDANCE IN PSORIATIC ARTHRITIS WHEN ANALYZING THE LINK BETWEEN PATIENT-PERCEIVED GOOD STATUS AND THE DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (DAPSA) COMPOSITE SCORE: AN ANALYSIS OF 436 PATIENTS FROM THE INTERNATIONAL REFLAP OBSERVATIONAL STUDY
https://doi.org/10.1136/annrheumdis-2019-eular.1207
Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study
https://doi.org/10.1136/rmdopen-2023-003157
SAT0635 PATIENT-PERCEIVED RESIDUAL BURDEN OF PSORIATIC ARTHRITIS IN PATIENTS IN REMISSION/LOW DISEASE: AN ANALYSIS OF 444 PATIENTS
https://doi.org/10.1136/annrheumdis-2019-eular.1206
POS1076 OBESITY IS ASSOCIATED WITH LESS LIKELIHOOD OF REMISSION/ LOW DISEASE IN PSORIATIC ARTHRITIS, A CROSS-SECTIONAL STUDY OF 414 PATIENTS
https://doi.org/10.1136/annrheumdis-2022-eular.2099
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries
https://doi.org/10.1136/rmdopen-2021-002031
POS0004 WHAT DOES WORSENING IN DAPSA DISEASE ACTIVITY CATEGORIES MEAN FOR PATIENTS WITH PSORIATIC ARTHRITIS? AN ANALYSIS OF 222 PATIENTS
https://doi.org/10.1136/annrheumdis-2022-eular.1493
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries
https://doi.org/10.1136/annrheumdis-2018-214140
SAT0318 Do patients in remission in psoriatic arthritis, have less fatigue? and does this depend on the definition of remission? an analysis of 304 patients
https://doi.org/10.1136/annrheumdis-2018-eular.3106
SAT0664 RESPONSIVENESS OF PATIENT-REPORTED PHYSICAL FUNCTION OUTCOME MEASURES IN A REAL LIFE INTERNATIONAL COHORT OF 405 PATIENTS WITH PSORIATIC ARTHRITIS
https://doi.org/10.1136/annrheumdis-2019-eular.6761
OP0298 ARE PATIENTS WITH PSORIATIC ARTHRITIS BEING TREATED OPTIMALLY ACROSS THE WORLD? DISPARITIES IN HEALTH CARE FOR PATIENTS WITH PSORIATIC ARTHRITIS ACROSS COUNTRIES WITH DIFFERENT GDP'S, AN ANALYSIS OF 429 PATIENTS FROM 13 COUNTRIES
https://doi.org/10.1136/annrheumdis-2021-eular.1120
-
Funding
Funding for this research was provided by:
BRC
Department of Health and Social Care
National Institute for Health Research
Oxford Biomedical Research
Pfizer
NIHR
National Institute for Health and Care Research
Clinical Research Network
- License Information
